RPL10 (ribosomal protein L10) by Goel, M & Tamuli, R









Atlas Genet Cytogenet Oncol Haematol. 2011; 15(5)  425 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
RPL10 (ribosomal protein L10) 
Mohit Goel, Ranjan Tamuli 
Department of Biotechnology, Indian Institute of Technology Guwahati, Guwahati-781 039, Assam, India 
(MG, RT) 
 
Published in Atlas Database: August 2010 
Online updated version : http://AtlasGeneticsOncology.org/Genes/RPL10ID42148chXq28.html 
DOI: 10.4267/2042/45018 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: DKFZp686J1851, DXS648, DXS648E, 
FLJ23544, FLJ27072, NOV, QM 




DNA size 3.96 kb, mRNA size 2172 bp, 7 exons. The 
RPL10 gene is co-transcribed with the small nucleolar 
RNA gene U70 that is located in its fifth intron. 
Multiple processed pseudogenes of the gene RPL10 are 
dispersed in the genome. Moreover, transcript variants 
utilizing alternative polyA  
signals exist; the variant with the longest 3' UTR 




214 amino acids; 24604 Da. The protein is a 
component of the large ribosomal (60S) subunit and 
belongs to the L10E family of ribosomal proteins. 
Three natural variants of the RPL10 protein, 
VAR_006922 (N202S, dbSNP rs4909 and dbSNP 
rs12012747), VAR_027795 (L206M), and 
VAR_027796 (H213Q) have been reported. 
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Expression 
Ubiquitous. RPL10 is expressed in a wide variety  
of embryonic and adult tissues, down-regulated during 




The ribosomal protein L10 (RPL10), a member of the 
L10E family of ribosomal proteins, is a key protein in 
assembling 60S ribosomal subunit and organizes the 
architecture of the aminoacyl-tRNA binding site. 
RPL10 was originally identified as QM, a candidate for 
a Wilms' tumor suppressor; however, later studies dd 
not support the original hypothesis. In vitro studies 
have shown the interaction of RPL10 with the 
transcript regulator the c-Jun, as well as with the proto-
oncogene c-Yes; however, these interactions yet to 
demonstrate in vivo. 
Homology 
The percent identity below represents identity of 
RPL10 over an aligned region in UniGene. 
- Mus musculus: 100 (percent identity) 
- Xenopus tropicalis: 99.5 
- Monodelphis domestica: 99.5 
- Pan troglodytes: 99.5 
- Xenopus laevis: 99.1 
- Danio rerio: 97.7 
- Drosophila melanogaster: 88.9 
- Caenorhabditis elegans: 85.5 
- Neurospora crassa: 84.7 
- Saccharomyces cerevisiae: 78.3 
Mutations 
Note 
Two missense mutations L206M and H213Q at the C-
terminal end of RPL10 were identified in two 





RPL10 gene showed up-regulation in androgen-
independent C81 passage cells, derived from the 
LNCaP cell model that recapitulates prostate cancer 
progression. In a study using immunohistochemical 
technique, human prostatic tissues showed expression 
of RPL10 protein in all normal prostate glands adjacent 
to prostate cancer and in various intraepithelial 
neoplasia (PIN). However, in prostate cancer, the 
staining intensity and stained areas were decreased, 
compared to the normal glands and PIN lesions. There 
was an inverse correlation from normal to low-grade 
tumors and then to high-grade tumors. In high-grade 
tumors, the positive areas were mostly confined to 
peripheral aspects of tumors and were particularly  
strong in foci of perineural invasion. These results 
suggested that decreased RPL10 expression may be 
associated with early development of prostate cancer, 
but later a high level of RPL10 may facilitate 




Both adenine (A)/guanine (G) replacement was 
detected at the 605th nucleotide which changes the 
coding from serine to asparagines in 17 (58.6%) of the 
29 ovarian tumors studied. The frequencies of A/A, 
G/G and A/G homo- or hetero-zygosity were 3.5%, 
37.9% and 58.6%, respectively in cancer tissues but 
they were 26.1%, 52.2% and 21.7%, respectively in the 
adjacent normal tissues, indicating a higher 
heterozygous rate in cancer (58.6% vs 21.7%, p<0.01). 
These results suggest that high frequencies of loss of 
the A/G heterozygosity at the 605th nt of the RPL10 
gene may be associated with ovarian cancer. 
Wilms' tumor 
Note 
RPL10 was originally isolated by subtractive 
hybridization between a tumorigenic cell line (delet d 
for part of 11p) and a non-tumorigenic cell line (the 
tumorigenic cell line carrying an extra t(X;11) 
translocation chromosome). The RPL10 mRNA level 
was found modulated between the tumorigenic and 
nontumorigenic cell lines and suspected to be involved 
in the maintenance of the nontumorigenic phenotype. 
However, later study had shown that the RPL10 gene is 
X-linked and therefore not involved in suppression of 
tumorigenesis in Wilms' tumor. 
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